Literature DB >> 17081040

New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry.

Pierre Chaurand1, Jeremy L Norris, D Shannon Cornett, James A Mobley, Richard M Caprioli.   

Abstract

Molecular imaging of tissue by MALDI mass spectrometry is a powerful tool for visualizing the spatial distribution of constituent analytes with high molecular specificity. Although the technique is relatively young, it has already contributed to the understanding of many diverse areas of human health. In recent years, a great many advances in the practice of imaging mass spectrometry have taken place, making the technique more sensitive, robust, and ultimately useful. The purpose of this review is to highlight some of the more recent technological advances that have improved the efficiency of imaging mass spectrometry for clinical applications. Advances in the way MALDI mass spectrometry is integrated with histology, improved methods for automation, and better tools for data analysis are outlined in this review. Refined top-down strategies for the identification and validation of candidate biomarkers found in tissue sections are discussed. A clinical example highlighting the application of these methods to a cohort of clinical samples is described.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081040     DOI: 10.1021/pr060346u

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  85 in total

1.  Matrix sublimation/recrystallization for imaging proteins by mass spectrometry at high spatial resolution.

Authors:  Junhai Yang; Richard M Caprioli
Journal:  Anal Chem       Date:  2011-06-28       Impact factor: 6.986

2.  From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry.

Authors:  Pierre Chaurand; Dale S Cornett; Peggi M Angel; Richard M Caprioli
Journal:  Mol Cell Proteomics       Date:  2010-08-23       Impact factor: 5.911

Review 3.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Reagent precoated targets for rapid in-tissue derivatization of the anti-tuberculosis drug isoniazid followed by MALDI imaging mass spectrometry.

Authors:  M Lisa Manier; Michelle L Reyzer; Anne Goh; Veronique Dartois; Laura E Via; Clifton E Barry; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2011-05-13       Impact factor: 3.109

5.  Direct localisation of molecules in tissue sections of growing antler tips using MALDI imaging.

Authors:  Santanu Deb-Choudhury; Wenying Wang; Stefan Clerens; Chris McMahon; Jolon M Dyer; Chunyi Li
Journal:  Mol Cell Biochem       Date:  2015-08-11       Impact factor: 3.396

6.  Sublimation as a method of matrix application for mass spectrometric imaging.

Authors:  Joseph A Hankin; Robert M Barkley; Robert C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2007-06-30       Impact factor: 3.109

Review 7.  Does prostaglandin D2 hold the cure to male pattern baldness?

Authors:  Ashley Nieves; Luis A Garza
Journal:  Exp Dermatol       Date:  2014-04       Impact factor: 3.960

8.  Acyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer.

Authors:  Fredrick T Harris; S M Jamshedur Rahman; Mohamed Hassanein; Jun Qian; Megan D Hoeksema; Heidi Chen; Rosana Eisenberg; Pierre Chaurand; Richard M Caprioli; Masakazu Shiota; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-12

9.  MALDI Mass Spectrometry Imaging of Peptides in Medicago truncatula Root Nodules.

Authors:  Caitlin Keller; Erin Gemperline; Lingjun Li
Journal:  Methods Mol Biol       Date:  2020

10.  Automated assignment of ionization states in broad-mass matrix-assisted laser desorption/ionization spectra of protein mixtures.

Authors:  Dariya I Malyarenko; William E Cooke; Christine L Bunai; Dennis M Manos
Journal:  Rapid Commun Mass Spectrom       Date:  2010-01       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.